Österreichische Forschungs- und Technologiebericht 2010

R&D networks and regional knowledge production: an agent-based simulation of the Austrian competence centres programme

“…Private equity Uniform random distribution from EUR 0 to EUR 25,000 Probability per quarter of [41] 5 % Bank credit Uniform random distribution from EUR 0 to EUR 100,000 Initial financial stock of start-ups SME: Uniform random distribution from EUR 0 to EUR 70,000 minimum nominal capital for Austrian GmbH: EUR 35,000 [20] LE: Uniform random distribution from EUR 0 to EUR 100,000 minimum share capital for Austrian AG: EUR 50,000 [2] University: Uniform random distribution from EUR 0 to EUR 20,000 Research org. : Uniform random distribution from EUR 0 to EUR 20,000 Revenue per sold innovation Uniform random distribution from EUR 0 to EUR 100,000…”

Systems Biology in Austria 2011 - The Establishment of a New Field in a National Context

“…In 2010, the Austrian Federal Ministries of Science and Research (BMWF), for Transport, Innovation and Technology (BMVIT) and of Economy, Family and Youth (BMWFJ) commissioned an Austrian Research and Technology Report (Schibany et al 2010). This report mentions systems biology as a life science research field in which Austria participates in an ERA-NET and in transnational initiatives (medical systems biology and ELSA-GEN).…”

ERAWATCH country reports 2010: Austria

“…Considering the publication output, Austria's share in scientific publications worldwide is at 0.6%, and as to speed and subject matter it depends -like all other small countries -on global mega-trends (Schibany and Gassler, 2010 Regarding the number of often-cited researchers, which is an indication for the excellence of the research system, Austria ranges with 12 often cited researchers among the first 20 countries, but within considerable distance to the top-countries (BMWF, BMVIT, BMWFJ, 2009). This inconclusive pattern is probably mainly caused by the relatively low budget appropriations for basic research in Austria (0.41% of the GDP in 2009 or only 17% of all R&D expenditures).…”